Abstract
Background
More than half of small bowel neuroendocrine tumors (SB-NETs) are metastatic at diagnosis, but complete resection of the primary tumor and lymph node (LN) is recommended by most authors. Our aim was to describe the pattern of involved LN after an extensive LN resection.
Materials and Methods
Between July 2013 and December 2015, all consecutive patients who underwent resection of at least one SB-NET in our European Neuroendocrine Tumor Society Center of Excellence were prospectively included, while patients with duodenal SB-NETs were excluded. The resection and pathological analysis of LNs were standardized using three groups (group 1, along the small intestine; group 2, along the mesenteric vessel; and group 3, retropancreatic and mesenteric vessel origin).
Results
Twenty-eight patients with SB-NET resection were prospectively enrolled in the study, with seven patients being excluded from the analysis because it was impossible to divide the operative piece into nodal groups due to retractile mesenteritis. Among the remaining 21 patients, 20 (95 %) had LNs involved; 8 (38 %) in group 1, 13 (62 %) in group 2, and 12 (57 %) in group 3. Skip metastases were found in 14 patients (67 %): 4 (19 %) with an invasion pattern of group 3+ without group 2+, and 12 (57 %) with an invasion pattern of group 2+ or group 3+ without group 1+.
Conclusion
As a result of skip metastases, systematic, extensive LN resection in retropancreatic portion may be required to prevent unresectable locoregional recurrence.
Similar content being viewed by others
References
Modlin IM, Oberg K, Chung DC et al. Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol. 2008;9:61–72.
Boudreaux JP, Klimstra DS, Hassan MM, North American Neuroendocrine Tumor Society (NANETS), et al. The NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the jejunum, ileum, appendix, and cecum. Pancreas. 2010;39:753–66.
Niederle B, Pape UF, Costa F, et al. ENETS consensus guidelines update for neuroendocrine neoplasm of the jejunum and ileum. Neuroendocrinology. 2016;103(2):125–38.
Pasquer A, Walter T, Hervieu V, Forestier J, Scoazec J, Lombard-Bohas C, et al. Surgical management of small bowel neuroendocrine tumors: specific requirements and their impact on staging and prognosis. Ann Surg Oncol. 2015;22(Suppl 3):742–9
Lardière-Deguelte S, De Mestier L, Appéré F, et al. Toward a preoperative classification of lymph node metastases in patients with small intestinal neuroendocrine tumors in the era of intestinal-sparing surgery. Neuroendocrinology. 2016;103(5):552–9.
Japanese Gastric Cancer Association. Japanese classification of gastric cancer. 14th edition. Tokyo: Kanehara & Co. Ltd; 2010
Norlen O, Stalberg P, Oberg K, et al. Long-term results of surgery for small intestinal neuroendocrine tumors at a tertiary referral center. World J Surg. 2012;36:1419–31.
Landry CS, Lin HY, Phan A, et al. Resection of at-risk mesenteric lymph nodes is associated with improved survival in patients with small bowel neuroendocrine tumors. World J Surg. 2013;37:1695–700.
Author Contributions
Study conception and design: Arnaud Pasquer, Thomas Walter. Acquisition of data: Arnaud Pasquer, Gilles Poncet, Thomas Walter, Valerie Hervieu. Analysis and interpretation of data: Thomas Walter, Arnaud Pasquer. Drafting of manuscript: Arnaud Pasquer, Thomas Walter, Gilles Poncet, Pascal Rousset, Catherine Lombard-Bohas, Critical revision: All authors reviewed the manuscript before submission and agree with its contents.
Funding
None.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
DISCLOSURE
None.
Appendix
Appendix
See Table 2.
Rights and permissions
About this article
Cite this article
Pasquer, A., Walter, T., Rousset, P. et al. Lymphadenectomy during Small Bowel Neuroendocrine Tumor Surgery: The Concept of Skip Metastases. Ann Surg Oncol 23 (Suppl 5), 804–808 (2016). https://doi.org/10.1245/s10434-016-5574-8
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-016-5574-8